After $5B raise, critic asks Isomorphic Labs: five years and $7B+ spent, where are the drugs?

PatrickKidger · x · 2026-11-18

Mathematician Patrick Kidger revisits his critique of Isomorphic Labs. The company just raised $5B, but five years after founding and $7B+ in total, despite promising to cure all diseases, it appears to have cured none. He credits Iso's AF4 model as genuinely better on hard problems and doesn't want to understate the technical achievement, but insists success in AI drug discovery is measured in drugs, not models. A pointed critique of the gap between AI-for-Science narratives, capital enthusiasm, and actual output.

Original post →

More from Companies & People

Companies & People channel →